Collectively, our results demonstrate that delayed tPA treatment exacerbates ischemic brain injury, and IFNβ exerts a therapeutic potential to extend tPA therapeutic window to 4.5h post-injury and ameliorate delayed tPA-exacerbated brain injury in ischemic stroke. This evidence concerns the gene IFNB1 and ischemic stroke.